

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 4.92890499 |
| 2 | cytidine catabolic process (GO:0006216) | 4.92890499 |
| 3 | cytidine deamination (GO:0009972) | 4.92890499 |
| 4 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.92826378 |
| 5 | Golgi transport vesicle coating (GO:0048200) | 4.71299209 |
| 6 | COPI coating of Golgi vesicle (GO:0048205) | 4.71299209 |
| 7 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.69537218 |
| 8 | membrane raft organization (GO:0031579) | 4.35336150 |
| 9 | protein maturation by protein folding (GO:0022417) | 4.32177864 |
| 10 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.29346575 |
| 11 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.22108509 |
| 12 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.05793599 |
| 13 | actin nucleation (GO:0045010) | 3.98156644 |
| 14 | DNA deamination (GO:0045006) | 3.90133415 |
| 15 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.81385978 |
| 16 | regulation of defense response to virus by virus (GO:0050690) | 3.62367023 |
| 17 | T cell migration (GO:0072678) | 3.54498113 |
| 18 | lymphocyte chemotaxis (GO:0048247) | 3.47670563 |
| 19 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.42100746 |
| 20 | negative regulation of stress fiber assembly (GO:0051497) | 3.41046860 |
| 21 | negative regulation of cell size (GO:0045792) | 3.38895459 |
| 22 | NIK/NF-kappaB signaling (GO:0038061) | 3.33698839 |
| 23 | GDP-mannose metabolic process (GO:0019673) | 3.29085647 |
| 24 | protein retention in ER lumen (GO:0006621) | 3.25372272 |
| 25 | negative regulation of T cell apoptotic process (GO:0070233) | 3.19312889 |
| 26 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.17362970 |
| 27 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 3.14109897 |
| 28 | thymic T cell selection (GO:0045061) | 3.11804650 |
| 29 | pinocytosis (GO:0006907) | 3.09102707 |
| 30 | protein localization to endosome (GO:0036010) | 3.08189646 |
| 31 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.07899041 |
| 32 | regulation of monocyte chemotaxis (GO:0090025) | 3.06023415 |
| 33 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.03335329 |
| 34 | positive regulation of lamellipodium assembly (GO:0010592) | 2.92747185 |
| 35 | nuclear envelope reassembly (GO:0031468) | 2.92631212 |
| 36 | mitotic nuclear envelope reassembly (GO:0007084) | 2.92631212 |
| 37 | positive thymic T cell selection (GO:0045059) | 2.90563279 |
| 38 | pentose-phosphate shunt (GO:0006098) | 2.90379081 |
| 39 | regulation of interleukin-8 secretion (GO:2000482) | 2.88146264 |
| 40 | eosinophil chemotaxis (GO:0048245) | 2.84267103 |
| 41 | lymphocyte migration (GO:0072676) | 2.82397236 |
| 42 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.81026446 |
| 43 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.76709258 |
| 44 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.75980324 |
| 45 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.75021782 |
| 46 | glucose catabolic process (GO:0006007) | 2.74489099 |
| 47 | barbed-end actin filament capping (GO:0051016) | 2.74329076 |
| 48 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.73637713 |
| 49 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.73069747 |
| 50 | regulation of T cell tolerance induction (GO:0002664) | 2.68783866 |
| 51 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.68334210 |
| 52 | macrophage chemotaxis (GO:0048246) | 2.66577815 |
| 53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.63946532 |
| 54 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.61590866 |
| 55 | regulation of chronic inflammatory response (GO:0002676) | 2.59991408 |
| 56 | hyaluronan catabolic process (GO:0030214) | 2.57965532 |
| 57 | positive regulation of macrophage differentiation (GO:0045651) | 2.56536768 |
| 58 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.53476775 |
| 59 | negative regulation of viral genome replication (GO:0045071) | 2.52429382 |
| 60 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.52266312 |
| 61 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.52266312 |
| 62 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.51555014 |
| 63 | eosinophil migration (GO:0072677) | 2.50699495 |
| 64 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.50649654 |
| 65 | negative regulation of monooxygenase activity (GO:0032769) | 2.50510285 |
| 66 | positive regulation of lamellipodium organization (GO:1902745) | 2.49697471 |
| 67 | regulation of T cell chemotaxis (GO:0010819) | 2.49614029 |
| 68 | positive regulation of T cell chemotaxis (GO:0010820) | 2.49614029 |
| 69 | platelet aggregation (GO:0070527) | 2.49410038 |
| 70 | negative regulation of viral release from host cell (GO:1902187) | 2.47417875 |
| 71 | positive regulation of lymphocyte migration (GO:2000403) | 2.47230904 |
| 72 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.46396118 |
| 73 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.46085688 |
| 74 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.45921553 |
| 75 | hemidesmosome assembly (GO:0031581) | 2.45811787 |
| 76 | positive regulation of tolerance induction (GO:0002645) | 2.42152136 |
| 77 | negative T cell selection (GO:0043383) | 2.41333020 |
| 78 | regulation of integrin activation (GO:0033623) | 2.41328971 |
| 79 | regulation of mitochondrial membrane potential (GO:0051881) | 2.38923189 |
| 80 | regulation of metalloenzyme activity (GO:0048552) | 2.36084731 |
| 81 | membrane protein ectodomain proteolysis (GO:0006509) | 2.34821532 |
| 82 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.34327493 |
| 83 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.33608978 |
| 84 | regulation of lymphocyte migration (GO:2000401) | 2.32655207 |
| 85 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.32629472 |
| 86 | NADPH regeneration (GO:0006740) | 2.32433264 |
| 87 | pentose metabolic process (GO:0019321) | 2.31838956 |
| 88 | regulation of mononuclear cell migration (GO:0071675) | 2.29833172 |
| 89 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.29719638 |
| 90 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.29257034 |
| 91 | cellular zinc ion homeostasis (GO:0006882) | 2.29135180 |
| 92 | iron-sulfur cluster assembly (GO:0016226) | 2.29118538 |
| 93 | metallo-sulfur cluster assembly (GO:0031163) | 2.29118538 |
| 94 | regulation of translational termination (GO:0006449) | 2.27224299 |
| 95 | positive regulation of interleukin-4 production (GO:0032753) | 2.26614647 |
| 96 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.25599283 |
| 97 | sequestering of actin monomers (GO:0042989) | 2.25124478 |
| 98 | T cell selection (GO:0045058) | 2.23531098 |
| 99 | regulation of T cell apoptotic process (GO:0070232) | 2.22528813 |
| 100 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.22331740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.21344297 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.32129620 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.16876460 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.54314204 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.53385342 |
| 6 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.49795219 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.48585921 |
| 8 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.45992154 |
| 9 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.33717771 |
| 10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.29806237 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.14585234 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12453910 |
| 13 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.02795328 |
| 14 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90313144 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.83992463 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.79067061 |
| 17 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.78134963 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.75603359 |
| 19 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.74979030 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 1.68513595 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64077943 |
| 22 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.58497408 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 1.54131195 |
| 24 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.52447844 |
| 25 | UTX_26944678_Chip-Seq_JUKART_Human | 1.50355757 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.49927261 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.49744367 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.49156856 |
| 29 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.48485176 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.47788646 |
| 31 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.47711367 |
| 32 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.47538172 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.47296544 |
| 34 | P68_20966046_ChIP-Seq_HELA_Human | 1.47107662 |
| 35 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.46188794 |
| 36 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.45936863 |
| 37 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.45905110 |
| 38 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44984525 |
| 39 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.43479396 |
| 40 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41546830 |
| 41 | MAF_26560356_Chip-Seq_TH2_Human | 1.40884970 |
| 42 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.40121666 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40055250 |
| 44 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.36183360 |
| 45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34610251 |
| 46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.33650170 |
| 47 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.33469768 |
| 48 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.31500307 |
| 49 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.31480010 |
| 50 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.31320032 |
| 51 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29725212 |
| 52 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.29356927 |
| 53 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.28106366 |
| 54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.27894321 |
| 55 | ATF3_27146783_Chip-Seq_COLON_Human | 1.26216222 |
| 56 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.26120069 |
| 57 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24426533 |
| 58 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.22531542 |
| 59 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.22303047 |
| 60 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.22067178 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.20783459 |
| 62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.19851912 |
| 63 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18504832 |
| 64 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18348144 |
| 65 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.18221809 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16023664 |
| 67 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.15249173 |
| 68 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14981364 |
| 69 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14792711 |
| 70 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14188808 |
| 71 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14094392 |
| 72 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.13842671 |
| 73 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.13820687 |
| 74 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.13196867 |
| 75 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.11307958 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09346708 |
| 77 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.08826072 |
| 78 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.07265932 |
| 79 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06559420 |
| 80 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.05287299 |
| 81 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05247189 |
| 82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05133257 |
| 83 | MYB_26560356_Chip-Seq_TH2_Human | 1.02140653 |
| 84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01215163 |
| 85 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99746186 |
| 86 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.99312819 |
| 87 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.99056347 |
| 88 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.98886923 |
| 89 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98744294 |
| 90 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98352845 |
| 91 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.98134136 |
| 92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97642195 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97141299 |
| 94 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.97054151 |
| 95 | SPI1_23127762_ChIP-Seq_K562_Human | 0.96501715 |
| 96 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.96431409 |
| 97 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.96091097 |
| 98 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.96065136 |
| 99 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.95865808 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94952744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 3.12235560 |
| 2 | MP0005058_abnormal_lysosome_morphology | 2.89328044 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 2.87592189 |
| 4 | MP0005671_abnormal_response_to | 2.82212325 |
| 5 | MP0005257_abnormal_intraocular_pressure | 2.72501973 |
| 6 | MP0009333_abnormal_splenocyte_physiolog | 2.56732910 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.48372315 |
| 8 | MP0005464_abnormal_platelet_physiology | 2.44339776 |
| 9 | MP0009785_altered_susceptibility_to | 2.43991495 |
| 10 | MP0003566_abnormal_cell_adhesion | 2.41328582 |
| 11 | MP0005451_abnormal_body_composition | 2.35149001 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.27288189 |
| 13 | MP0003436_decreased_susceptibility_to | 2.13852289 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.03273674 |
| 15 | MP0004947_skin_inflammation | 2.00075026 |
| 16 | MP0000858_altered_metastatic_potential | 1.96171784 |
| 17 | MP0008260_abnormal_autophagy | 1.91031602 |
| 18 | MP0003448_altered_tumor_morphology | 1.85420709 |
| 19 | MP0006082_CNS_inflammation | 1.84277020 |
| 20 | MP0004272_abnormal_basement_membrane | 1.80202517 |
| 21 | MP0003763_abnormal_thymus_physiology | 1.79556339 |
| 22 | MP0005025_abnormal_response_to | 1.78217581 |
| 23 | MP0001542_abnormal_bone_strength | 1.77392699 |
| 24 | MP0005000_abnormal_immune_tolerance | 1.75623715 |
| 25 | MP0009840_abnormal_foam_cell | 1.75233156 |
| 26 | MP0001835_abnormal_antigen_presentation | 1.73832829 |
| 27 | MP0004233_abnormal_muscle_weight | 1.70308411 |
| 28 | MP0000343_altered_response_to | 1.69416995 |
| 29 | MP0003279_aneurysm | 1.68970105 |
| 30 | MP0003075_altered_response_to | 1.64306097 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.64017342 |
| 32 | MP0005623_abnormal_meninges_morphology | 1.58508420 |
| 33 | MP0003453_abnormal_keratinocyte_physiol | 1.57047123 |
| 34 | MP0002796_impaired_skin_barrier | 1.53182770 |
| 35 | MP0005023_abnormal_wound_healing | 1.49951409 |
| 36 | MP0004510_myositis | 1.48500402 |
| 37 | MP0001849_ear_inflammation | 1.47889571 |
| 38 | MP0001853_heart_inflammation | 1.42798066 |
| 39 | MP0005501_abnormal_skin_physiology | 1.38904933 |
| 40 | MP0003091_abnormal_cell_migration | 1.37057435 |
| 41 | MP0001873_stomach_inflammation | 1.37010000 |
| 42 | MP0002723_abnormal_immune_serum | 1.33112552 |
| 43 | MP0002060_abnormal_skin_morphology | 1.32983792 |
| 44 | MP0003866_abnormal_defecation | 1.32050166 |
| 45 | MP0002420_abnormal_adaptive_immunity | 1.31901274 |
| 46 | MP0002419_abnormal_innate_immunity | 1.31334227 |
| 47 | MP0010155_abnormal_intestine_physiology | 1.30699310 |
| 48 | MP0000678_abnormal_parathyroid_gland | 1.30335847 |
| 49 | MP0001819_abnormal_immune_cell | 1.29369000 |
| 50 | MP0010368_abnormal_lymphatic_system | 1.28017369 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.26639898 |
| 52 | MP0001958_emphysema | 1.23456417 |
| 53 | MP0000751_myopathy | 1.22101154 |
| 54 | MP0002452_abnormal_antigen_presenting | 1.20724029 |
| 55 | MP0000685_abnormal_immune_system | 1.20523735 |
| 56 | MP0005166_decreased_susceptibility_to | 1.19054628 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.18945109 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.17126456 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.16893175 |
| 60 | MP0003303_peritoneal_inflammation | 1.15688878 |
| 61 | MP0001243_abnormal_dermal_layer | 1.14968319 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.13374378 |
| 63 | MP0002405_respiratory_system_inflammati | 1.12606852 |
| 64 | MP0001216_abnormal_epidermal_layer | 1.12122800 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 1.10884506 |
| 66 | MP0000749_muscle_degeneration | 1.09786182 |
| 67 | MP0005165_increased_susceptibility_to | 1.09350395 |
| 68 | MP0001790_abnormal_immune_system | 1.07843176 |
| 69 | MP0005387_immune_system_phenotype | 1.07843176 |
| 70 | MP0002398_abnormal_bone_marrow | 1.07475053 |
| 71 | MP0002722_abnormal_immune_system | 1.06617076 |
| 72 | MP0000716_abnormal_immune_system | 1.02928745 |
| 73 | MP0008469_abnormal_protein_level | 1.01643239 |
| 74 | MP0000467_abnormal_esophagus_morphology | 1.01169703 |
| 75 | MP0003045_fibrosis | 1.01059222 |
| 76 | MP0004858_abnormal_nervous_system | 0.99354515 |
| 77 | MP0002429_abnormal_blood_cell | 0.97600453 |
| 78 | MP0005410_abnormal_fertilization | 0.97259562 |
| 79 | MP0001800_abnormal_humoral_immune | 0.97221010 |
| 80 | MP0002166_altered_tumor_susceptibility | 0.96603759 |
| 81 | MP0005330_cardiomyopathy | 0.95936046 |
| 82 | MP0005390_skeleton_phenotype | 0.95739791 |
| 83 | MP0010234_abnormal_vibrissa_follicle | 0.95449508 |
| 84 | MP0000750_abnormal_muscle_regeneration | 0.93070412 |
| 85 | MP0009764_decreased_sensitivity_to | 0.91557324 |
| 86 | MP0000604_amyloidosis | 0.91517299 |
| 87 | MP0000767_abnormal_smooth_muscle | 0.91451514 |
| 88 | MP0000703_abnormal_thymus_morphology | 0.91207716 |
| 89 | MP0002006_tumorigenesis | 0.89067156 |
| 90 | MP0003329_amyloid_beta_deposits | 0.88465102 |
| 91 | MP0003806_abnormal_nucleotide_metabolis | 0.87177151 |
| 92 | MP0001348_abnormal_lacrimal_gland | 0.84704410 |
| 93 | MP0005083_abnormal_biliary_tract | 0.83982743 |
| 94 | MP0009763_increased_sensitivity_to | 0.83669120 |
| 95 | MP0005275_abnormal_skin_tensile | 0.83438618 |
| 96 | MP0003795_abnormal_bone_structure | 0.83109604 |
| 97 | MP0006054_spinal_hemorrhage | 0.81652307 |
| 98 | MP0000689_abnormal_spleen_morphology | 0.81237531 |
| 99 | MP0002933_joint_inflammation | 0.81227303 |
| 100 | MP0000490_abnormal_crypts_of | 0.78881990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 4.26298475 |
| 2 | Distal lower limb muscle weakness (HP:0009053) | 3.65845774 |
| 3 | Vertebral compression fractures (HP:0002953) | 3.55183201 |
| 4 | Protrusio acetabuli (HP:0003179) | 3.31693058 |
| 5 | Distal lower limb amyotrophy (HP:0008944) | 3.22560239 |
| 6 | Aplastic anemia (HP:0001915) | 3.14642905 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.13807586 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 3.09218776 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.09218776 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.09218776 |
| 11 | Petechiae (HP:0000967) | 3.08021102 |
| 12 | J-shaped sella turcica (HP:0002680) | 3.05654667 |
| 13 | Rough bone trabeculation (HP:0100670) | 2.70439529 |
| 14 | Upper limb amyotrophy (HP:0009129) | 2.65062076 |
| 15 | Distal upper limb amyotrophy (HP:0007149) | 2.65062076 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 2.63280705 |
| 17 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.63277897 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.55805341 |
| 19 | Atrophic scars (HP:0001075) | 2.53634229 |
| 20 | Increased IgM level (HP:0003496) | 2.49795076 |
| 21 | Spinal rigidity (HP:0003306) | 2.46963064 |
| 22 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.46232957 |
| 23 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.43740337 |
| 24 | Dysostosis multiplex (HP:0000943) | 2.43371612 |
| 25 | Short nail (HP:0001799) | 2.39421539 |
| 26 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.38807386 |
| 27 | Increased connective tissue (HP:0009025) | 2.38431154 |
| 28 | Vacuolated lymphocytes (HP:0001922) | 2.35418989 |
| 29 | Achilles tendon contracture (HP:0001771) | 2.34327673 |
| 30 | Increased serum ferritin (HP:0003281) | 2.33524173 |
| 31 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.30372958 |
| 32 | Osteolytic defects of the hand bones (HP:0009699) | 2.30372958 |
| 33 | Upper limb muscle weakness (HP:0003484) | 2.30224240 |
| 34 | Hepatosplenomegaly (HP:0001433) | 2.28784602 |
| 35 | Purpura (HP:0000979) | 2.28022547 |
| 36 | Abnormal gallbladder physiology (HP:0012438) | 2.22801734 |
| 37 | Cholecystitis (HP:0001082) | 2.22801734 |
| 38 | T lymphocytopenia (HP:0005403) | 2.22212161 |
| 39 | Generalized amyotrophy (HP:0003700) | 2.20141976 |
| 40 | Menorrhagia (HP:0000132) | 2.19949858 |
| 41 | Hyperacusis (HP:0010780) | 2.18914035 |
| 42 | Autoimmune hemolytic anemia (HP:0001890) | 2.18835488 |
| 43 | Exercise-induced myalgia (HP:0003738) | 2.17113929 |
| 44 | Hand muscle atrophy (HP:0009130) | 2.16215831 |
| 45 | Broad face (HP:0000283) | 2.15959440 |
| 46 | Nail dystrophy (HP:0008404) | 2.14870823 |
| 47 | Trismus (HP:0000211) | 2.13304399 |
| 48 | Abnormality of the Achilles tendon (HP:0005109) | 2.10008228 |
| 49 | Cervical subluxation (HP:0003308) | 2.07833969 |
| 50 | Thick nail (HP:0001805) | 2.07641888 |
| 51 | Difficulty climbing stairs (HP:0003551) | 2.07106881 |
| 52 | Abnormal trabecular bone morphology (HP:0100671) | 2.06354689 |
| 53 | Lower limb amyotrophy (HP:0007210) | 2.04694653 |
| 54 | Fragile skin (HP:0001030) | 2.02676945 |
| 55 | Hypertriglyceridemia (HP:0002155) | 2.02513779 |
| 56 | Elbow flexion contracture (HP:0002987) | 2.02440219 |
| 57 | Abnormality of the umbilical cord (HP:0010881) | 2.02270451 |
| 58 | Increased mean platelet volume (HP:0011877) | 2.02259076 |
| 59 | Prolonged neonatal jaundice (HP:0006579) | 2.01604969 |
| 60 | Abnormality of T cell number (HP:0011839) | 1.98240867 |
| 61 | Epistaxis (HP:0000421) | 1.97371425 |
| 62 | Abnormal platelet function (HP:0011869) | 1.96714607 |
| 63 | Impaired platelet aggregation (HP:0003540) | 1.96714607 |
| 64 | Abnormal platelet volume (HP:0011876) | 1.94685852 |
| 65 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.94581501 |
| 66 | Nonimmune hydrops fetalis (HP:0001790) | 1.94021413 |
| 67 | Asymmetric septal hypertrophy (HP:0001670) | 1.93574988 |
| 68 | Ankle contracture (HP:0006466) | 1.92095948 |
| 69 | Ragged-red muscle fibers (HP:0003200) | 1.89769560 |
| 70 | Progressive neurologic deterioration (HP:0002344) | 1.88180091 |
| 71 | Dilatation of the ascending aorta (HP:0005111) | 1.84145709 |
| 72 | Fasciculations (HP:0002380) | 1.82332814 |
| 73 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.81449868 |
| 74 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.81449868 |
| 75 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.81449868 |
| 76 | Blue sclerae (HP:0000592) | 1.80557777 |
| 77 | Deformed sella turcica (HP:0002681) | 1.80105099 |
| 78 | Chronic obstructive pulmonary disease (HP:0006510) | 1.78158545 |
| 79 | Obstructive lung disease (HP:0006536) | 1.78158545 |
| 80 | Entropion (HP:0000621) | 1.76144479 |
| 81 | Increased variability in muscle fiber diameter (HP:0003557) | 1.72795259 |
| 82 | Natal tooth (HP:0000695) | 1.72141853 |
| 83 | Spastic paraparesis (HP:0002313) | 1.71859462 |
| 84 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.71372664 |
| 85 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.71372664 |
| 86 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.69878302 |
| 87 | Easy fatigability (HP:0003388) | 1.69532152 |
| 88 | Micronodular cirrhosis (HP:0001413) | 1.68778493 |
| 89 | Loss of speech (HP:0002371) | 1.68673227 |
| 90 | Hypertensive crisis (HP:0100735) | 1.68412527 |
| 91 | Glucose intolerance (HP:0000833) | 1.67625624 |
| 92 | Onycholysis (HP:0001806) | 1.67554750 |
| 93 | Abnormality of oral frenula (HP:0000190) | 1.66676541 |
| 94 | Ureteral stenosis (HP:0000071) | 1.66673468 |
| 95 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.65570759 |
| 96 | Mucopolysacchariduria (HP:0008155) | 1.65570759 |
| 97 | Hypokinesia (HP:0002375) | 1.64978526 |
| 98 | Acute hepatic failure (HP:0006554) | 1.64749725 |
| 99 | Myocardial infarction (HP:0001658) | 1.64179892 |
| 100 | Hyperparathyroidism (HP:0000843) | 1.63507790 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 5.91160694 |
| 2 | TESK1 | 4.30081371 |
| 3 | IRAK3 | 3.90152031 |
| 4 | KDR | 3.48306752 |
| 5 | EPHA2 | 2.96778773 |
| 6 | NME2 | 2.87864106 |
| 7 | TRIB3 | 2.22957707 |
| 8 | LIMK1 | 2.22381475 |
| 9 | ERN1 | 1.98220213 |
| 10 | ARAF | 1.97845230 |
| 11 | PIM2 | 1.97483804 |
| 12 | BCKDK | 1.96517947 |
| 13 | MAPKAPK3 | 1.91461214 |
| 14 | SMG1 | 1.89889230 |
| 15 | TAOK2 | 1.86771133 |
| 16 | VRK2 | 1.86044888 |
| 17 | SIK1 | 1.85917172 |
| 18 | PAK4 | 1.72227320 |
| 19 | MAP3K11 | 1.68160450 |
| 20 | MAP4K1 | 1.66282643 |
| 21 | MST1R | 1.65094970 |
| 22 | LMTK2 | 1.61557102 |
| 23 | TXK | 1.56202859 |
| 24 | SCYL2 | 1.55242016 |
| 25 | TTN | 1.50660188 |
| 26 | BUB1 | 1.42962188 |
| 27 | MAP3K3 | 1.32637048 |
| 28 | PRPF4B | 1.27451271 |
| 29 | MUSK | 1.26011733 |
| 30 | TBK1 | 1.12328519 |
| 31 | DDR2 | 1.11344615 |
| 32 | TAOK1 | 1.05753054 |
| 33 | DAPK1 | 1.05706694 |
| 34 | ICK | 1.05191137 |
| 35 | PKN2 | 1.01453064 |
| 36 | ZAP70 | 1.00402562 |
| 37 | CSK | 0.90938915 |
| 38 | ITK | 0.85869764 |
| 39 | PTK2 | 0.85662926 |
| 40 | GRK6 | 0.85146955 |
| 41 | MYLK | 0.84158270 |
| 42 | BMX | 0.81981938 |
| 43 | ABL2 | 0.77916439 |
| 44 | CDK8 | 0.76349763 |
| 45 | RIPK1 | 0.73542480 |
| 46 | ILK | 0.72981062 |
| 47 | EPHB1 | 0.72069649 |
| 48 | MOS | 0.70490692 |
| 49 | AURKA | 0.70191010 |
| 50 | STK10 | 0.68076394 |
| 51 | MAP2K3 | 0.67548863 |
| 52 | PDGFRA | 0.67076994 |
| 53 | PAK1 | 0.66902897 |
| 54 | CSF1R | 0.66621065 |
| 55 | MAP3K8 | 0.66305070 |
| 56 | PRKD2 | 0.64993862 |
| 57 | JAK3 | 0.61828085 |
| 58 | IRAK4 | 0.60787702 |
| 59 | TGFBR2 | 0.56967447 |
| 60 | IKBKB | 0.54821774 |
| 61 | MAPKAPK2 | 0.53128262 |
| 62 | CDK7 | 0.52080598 |
| 63 | PRKG2 | 0.51110724 |
| 64 | MAP3K1 | 0.49983223 |
| 65 | CAMK2G | 0.49516570 |
| 66 | MAPK11 | 0.48378874 |
| 67 | TIE1 | 0.48198450 |
| 68 | PDPK1 | 0.46349274 |
| 69 | GRK7 | 0.45967030 |
| 70 | MET | 0.45541179 |
| 71 | FLT3 | 0.45097012 |
| 72 | RPS6KA2 | 0.43320958 |
| 73 | IKBKE | 0.42399395 |
| 74 | NTRK1 | 0.42103295 |
| 75 | LRRK2 | 0.40611915 |
| 76 | LCK | 0.38850657 |
| 77 | EPHB2 | 0.38587469 |
| 78 | DAPK3 | 0.38468621 |
| 79 | SIK3 | 0.37446457 |
| 80 | BRAF | 0.37377590 |
| 81 | BLK | 0.36222607 |
| 82 | PRKD3 | 0.35424144 |
| 83 | MAP3K12 | 0.34881934 |
| 84 | MATK | 0.34181582 |
| 85 | EIF2AK1 | 0.33415076 |
| 86 | RPS6KB2 | 0.33058340 |
| 87 | FGFR4 | 0.31866699 |
| 88 | TYK2 | 0.30328091 |
| 89 | PDK1 | 0.30209115 |
| 90 | PTK6 | 0.29579030 |
| 91 | RAF1 | 0.29154244 |
| 92 | MTOR | 0.29009333 |
| 93 | RIPK4 | 0.29007816 |
| 94 | PAK2 | 0.28863161 |
| 95 | CDC42BPA | 0.28636589 |
| 96 | STK38 | 0.28401916 |
| 97 | SYK | 0.27854028 |
| 98 | MAP3K5 | 0.27576270 |
| 99 | ROCK1 | 0.26995314 |
| 100 | PRKCI | 0.26855950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.28589891 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.07745563 |
| 3 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.58139290 |
| 4 | Shigellosis_Homo sapiens_hsa05131 | 2.44524412 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.33693312 |
| 6 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.27902535 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.22034140 |
| 8 | Salmonella infection_Homo sapiens_hsa05132 | 2.12087997 |
| 9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.02647211 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.97895765 |
| 11 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.85349572 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.77120459 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.74613864 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.74353286 |
| 15 | Bladder cancer_Homo sapiens_hsa05219 | 1.74327928 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.69772943 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 1.66417361 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.62524073 |
| 19 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.61547878 |
| 20 | Galactose metabolism_Homo sapiens_hsa00052 | 1.61492600 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.59971836 |
| 22 | Sulfur relay system_Homo sapiens_hsa04122 | 1.58299802 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.55666187 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.52457908 |
| 25 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.50870252 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.46024643 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.44369505 |
| 28 | Apoptosis_Homo sapiens_hsa04210 | 1.43978774 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.36634631 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.36532076 |
| 31 | Endocytosis_Homo sapiens_hsa04144 | 1.34134116 |
| 32 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.26275416 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.25133088 |
| 34 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.24237818 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.23347324 |
| 36 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.22642372 |
| 37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.21553460 |
| 38 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.17931099 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16570895 |
| 40 | Allograft rejection_Homo sapiens_hsa05330 | 1.16413971 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.16308926 |
| 42 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.14424467 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11188830 |
| 44 | Prion diseases_Homo sapiens_hsa05020 | 1.09754150 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 1.09369657 |
| 46 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.08552091 |
| 47 | Focal adhesion_Homo sapiens_hsa04510 | 1.06253722 |
| 48 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.06152774 |
| 49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.01460150 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.00539920 |
| 51 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.96825828 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90195375 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 0.85953690 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84363421 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83357299 |
| 56 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.83328077 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.82388448 |
| 58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.81764376 |
| 59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.80736304 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.80472269 |
| 61 | DNA replication_Homo sapiens_hsa03030 | 0.79637009 |
| 62 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79573882 |
| 63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79189983 |
| 64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.78842338 |
| 65 | Base excision repair_Homo sapiens_hsa03410 | 0.77453354 |
| 66 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77339511 |
| 67 | Phagosome_Homo sapiens_hsa04145 | 0.77104456 |
| 68 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.76714032 |
| 69 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75977265 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74346761 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73013165 |
| 72 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.72798087 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.72482205 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.70482001 |
| 75 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.70353676 |
| 76 | RNA polymerase_Homo sapiens_hsa03020 | 0.68095064 |
| 77 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67467287 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.64952988 |
| 79 | Tuberculosis_Homo sapiens_hsa05152 | 0.64397943 |
| 80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62181377 |
| 81 | Hepatitis B_Homo sapiens_hsa05161 | 0.62143957 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.61941006 |
| 83 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.61424016 |
| 84 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.61109087 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60668571 |
| 86 | Leishmaniasis_Homo sapiens_hsa05140 | 0.59622883 |
| 87 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57290696 |
| 88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56451023 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56086274 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55272907 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54793175 |
| 92 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.41922805 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41358269 |
| 94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.37197522 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36087612 |
| 96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.35209466 |
| 97 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.34403440 |
| 98 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.33598354 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33506243 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31078061 |

